EVP Pharmaceutical Division
Larry Westfall is currently engaged with strategies & services to implement value-based care with a focus on clinical decision support at the point of care and models of care utilizing innovative medication management to optimize clinical and economic outcomes. He was previously Director, Healthcare Quality Alliances for the Strategic Customer Group within Johnson & Johnson Health Care Systems. He was part of a team responsible for developing an understanding across Janssen Pharmaceuticals Companies of Johnson & Johnson of the changing dynamics within the US healthcare system and working across the organization to develop strategies to align company offerings with the needs of current and evolving healthcare delivery and payment models.
Prior to this role, Larry held positions within J&J of the National Director, Strategic Alliances in the Health, Policy, Advocacy & Quality division and the Director, Quality Management for the Johnson & Johnson Institutional Franchise where Larry was responsible for providing franchise-specific strategic quality planning & perspective on current health system practices and future healthcare environment strategies. During his tenure in this position, Larry was appointed and served as a Member of the National Quality Forum Care Coordination Workgroup.
Prior to joining Johnson & Johnson in 2005, Larry held a variety of leadership positions with Aventis Pharmaceuticals.
Larry received his BS in Pharmacy and Doctor of Pharmacy degrees from the University of Maryland and prior to his career in the pharmaceutical industry held several senior management pharmacy positions in the hospital, home care, and long term care segments. In addition, Larry has held faculty appointments at the University of Maryland School of Pharmacy and George Washington University School of Medicine where he taught geriatric pharmacotherapy.
Protect Patients & Bottom Lines. Contact Medsign.